✦ LIBER ✦

Intraperitoneal chemotherapy is appropriate first line therapy for patients with optimally debulked ovarian cancer

✍ Scribed by Maurie Markman

Book ID: 104375046
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 71 KB
Volume: 38
Category: Article
ISSN: 1040-8428
DOI: 10.1016/s1040-8428(01)00097-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Peritoneal fibrosis leading to small bow

Peritoneal fibrosis leading to small bowel obstruction two years after first-line intraperitoneal chemotherapy for optimally debulked ovarian cancer

✍ Warren S. W. CHAN; Robert BOHMER; Robert MCINTOSH; Penelope BLOMFIELD 📂 Article 📅 2010 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 105 KB

Intraperitoneal chemotherapy for optimal

Intraperitoneal chemotherapy for optimally debulked advanced ovarian cancer: A new standard in patient care?

✍ A. González Martín 📂 Article 📅 2007 🏛 Springer Milan 🌐 Spanish ⚖ 44 KB

Five-year survival for cisplatin-based c

Five-year survival for cisplatin-based chemotherapy versus single-agent melphalan in patients with advanced ovarian cancer and optimal debulking surgery

✍ M. Steven Piver; James Fanning; Henry E. Sprance 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 542 KB

The purpose of this study was to evaluate 5-year survival and 5-year progression-free survival in previously untreated patients with advanced ovarian cancer treated with single-agent melphalan in which very few patients underwent optimal debulking surgery (<2 cm residual) as compared with the patien

Usefulness of third-line chemotherapy fo

Usefulness of third-line chemotherapy for women with recurrent ovarian, fallopian tube, and primary peritoneal cancer who receive platinum/taxane regimens as first-line therapy

✍ Shin Nishio; Noriyuki Katsumata; Koji Matsumoto; Hiroshi Tanabe; Kan Yonemori; T 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 264 KB

Anemia is the strongest prognostic facto

Anemia is the strongest prognostic factor for outcomes of 5-fluorouracil-based first-line chemotherapy in patients with advanced gastric cancer

✍ Se Hoon Park; Jeeyun Lee; Se Hoon Lee; Joon Oh Park; Kihyun Kim; Won Seog Kim; C 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 199 KB

An individual patient-based meta-analysi

An individual patient-based meta-analysis of tamoxifen versus ovarian ablation as first line endocrine therapy for premenopausal women with metastatic breast cancer

✍ Michael Crump; Carol A. Sawka; Gerrit DeBoer; Roger B. Buchanan; James N. Ingle; 📂 Article 📅 1997 🏛 Springer US 🌐 English ⚖ 61 KB